Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Leibundgut, Gregor
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation	Recruiting	4	3010	Europe	P2Y12 inhibitor, Aspirin, DOAC	Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited	Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor	09/26	12/26
NCT04859985: The SELUTION DeNovo Study	Active, not recruiting	N/A	3326	Europe, RoW	SELUTION SLR, DES	M.A. Med Alliance S.A.	Coronary Artery Disease	08/25	07/30
NCT03587922: FANTOM Post Market Clinical Trial	Recruiting	N/A	1500	Europe	Fantom	REVA Medical, Inc.	Coronary Artery Disease	05/25	05/25
NCT06055920: The PEERLESS II Study	Recruiting	N/A	1200	Europe, Canada, US	FlowTriever System, Anticoagulation Agents	Inari Medical	Pulmonary Embolism	07/26	07/26
NAGOMI COMPLEX, NCT05705973: Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients	Recruiting	N/A	3000	Europe	Ultimaster Nagomi™	Terumo Europe N.V.	Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease	09/26	09/27